Status:
COMPLETED
Etanercept (Enbrel®) in Psoriasis - Pediatrics
Lead Sponsor:
Amgen
Conditions:
Psoriasis
Eligibility:
All Genders
4-17 years
Phase:
PHASE3
Brief Summary
This study will evaluate the safety and efficacy of etanercept (Enbrel®) in children with Psoriasis.
Detailed Description
On enrollment, participants underwent randomization in a 1:1 ratio to receive placebo or etanercept during the initial double-blind period. Participants could enter an escape group and receive open-la...
Eligibility Criteria
Inclusion
- Patients with plaque psoriasis
- Patient may not receive certain psoriasis medications during the study
Exclusion
Key Trial Info
Start Date :
September 8 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2007
Estimated Enrollment :
211 Patients enrolled
Trial Details
Trial ID
NCT00078819
Start Date
September 8 2004
End Date
June 1 2007
Last Update
July 29 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.